It seems the content you want summarized is missing or unspecified. Please provide the content you need summarized, and I'll be happy to help!
RDY has been in the news recently: Pierre Fabre Laboratories has acquired the global rights to develop PFL-721 and PFL-241, mutant-specific EGFR inhibitors aimed at treating non-small cell lung cancer. Additionally, King Faisal Specialist Hospital & Research Centre and Germfree Laboratories are establishing Saudi Arabia's first ATMP Manufacturing Campus to advance biotech initiatives by 2040.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!